NCT06907342View on ClinicalTrials.gov

Testing a Functional Precision Medicine Approach to Select Chemotherapy for Metastatic Colorectal Cancer (COSENSE-1)

PHASE2RecruitingINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

May 23, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

September 30, 2040

Conditions
Tumor, ColorectalOrganoidsTumoroidMetastatic Colorectal CancerCore Needle BiopsyFirst-line Treatment
Interventions
DRUG

FOLFOX or FOLFIRI

Treatment allocation from tumouroid readout

Trial Locations (1)

Unknown

RECRUITING

St. Olavs Hospital, Trondheim

All Listed Sponsors
collaborator

Norwegian University of Science and Technology

OTHER

lead

St. Olavs Hospital

OTHER

NCT06907342 - Testing a Functional Precision Medicine Approach to Select Chemotherapy for Metastatic Colorectal Cancer (COSENSE-1) | Biotech Hunter | Biotech Hunter